Stay updated on Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Locations have been added by state (CA, DC, GA, MN, MO, NJ, NY, OH, TX) under a new Locations section; the HHS Vulnerability Disclosure link was removed, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T21:33:21.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill publication notice and updated the revision from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:16:26.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Notice about government funding and operating status is removed from the page. The remaining study details, eligibility criteria, participating locations, and planned outcomes are unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:11:00.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The new screenshot shows only minor formatting adjustments and small administrative updates to the Study Details page; there are no changes to core study information such as eligibility criteria, primary outcomes, or treatment regimen. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:06:36.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    - Updated operating status notice and references; bumped version to v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:33:39.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:07:02.000Z thumbnail image

Stay in the know with updates to Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.